Novavax Inc (NVAX)
4.075
+0.12
(+3.16%)
USD |
NASDAQ |
Apr 26, 14:23
Novavax Market Cap: 570.31M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 552.81M |
| April 24, 2024 | 580.81M |
| April 23, 2024 | 586.40M |
| April 22, 2024 | 569.61M |
| April 19, 2024 | 555.61M |
| April 18, 2024 | 544.42M |
| April 17, 2024 | 544.42M |
| April 16, 2024 | 558.41M |
| April 15, 2024 | 576.61M |
| April 12, 2024 | 599.00M |
| April 11, 2024 | 601.80M |
| April 10, 2024 | 596.20M |
| April 09, 2024 | 618.59M |
| April 08, 2024 | 619.99M |
| April 05, 2024 | 618.59M |
| April 04, 2024 | 621.39M |
| April 03, 2024 | 635.39M |
| April 02, 2024 | 633.99M |
| April 01, 2024 | 650.78M |
| March 28, 2024 | 668.98M |
| March 27, 2024 | 678.77M |
| March 26, 2024 | 659.18M |
| March 25, 2024 | 673.17M |
| March 22, 2024 | 657.78M |
| March 21, 2024 | 660.58M |
| Date | Value |
|---|---|
| March 20, 2024 | 675.97M |
| March 19, 2024 | 691.37M |
| March 18, 2024 | 719.36M |
| March 15, 2024 | 740.35M |
| March 14, 2024 | 696.97M |
| March 13, 2024 | 734.75M |
| March 12, 2024 | 708.16M |
| March 11, 2024 | 717.96M |
| March 08, 2024 | 762.74M |
| March 07, 2024 | 785.14M |
| March 06, 2024 | 785.14M |
| March 05, 2024 | 779.54M |
| March 04, 2024 | 768.34M |
| March 01, 2024 | 754.35M |
| February 29, 2024 | 691.37M |
| February 28, 2024 | 617.19M |
| February 27, 2024 | 842.52M |
| February 26, 2024 | 769.74M |
| February 23, 2024 | 740.35M |
| February 22, 2024 | 680.79M |
| February 21, 2024 | 555.23M |
| February 20, 2024 | 576.16M |
| February 16, 2024 | 580.34M |
| February 15, 2024 | 599.87M |
| February 14, 2024 | 571.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
96.17M
Minimum
Aug 12 2019
22.99B
Maximum
Feb 08 2021
4.704B
Average
1.462B
Median
Market Cap Benchmarks
| Pfizer Inc | 143.82B |
| Moderna Inc | 41.19B |
| Agilent Technologies Inc | 40.47B |
| Lexicon Pharmaceuticals Inc | 391.52M |
| Vaxart Inc | 120.33M |
Market Cap Related Metrics
| PS Ratio | 0.6134 |
| Price | 4.075 |
| Earnings Yield | -136.4% |